Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors

Immunotherapy represents the new era of cancer treatment because of its promising results in various cancer types. In urological tumors, the use of the immune-checkpoint inhibitors (ICIs) is increasingly spreading. Although not all patients and not all diseases respond equally well to immunotherapy,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Oncol
Autors principals: Schepisi, Giuseppe, Brighi, Nicole, Cursano, Maria Concetta, Gurioli, Giorgia, Ravaglia, Giorgia, Altavilla, Amelia, Burgio, Salvatore Luca, Testoni, Sara, Menna, Cecilia, Farolfi, Alberto, Casadei, Chiara, Tonini, Giuseppe, Santini, Daniele, De Giorgi, Ugo
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2019
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6770345/
https://ncbi.nlm.nih.gov/pubmed/31641355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7317964
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars